rethinkPeptides Search
Menu
Research citation

Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.

Advances in therapy, 42(10), 5055-5071

Citation

Capehorn, Matthew; Johansson, Erin; Davies, Alun; Evans, Jerome; Godbeer, Fiona; van Hest, Naomi; Cotterill, Georgina; Tolley, Keith. (2025). Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.. Advances in therapy, 42(10), 5055-5071. https://doi.org/10.1007/s12325-025-03288-3